Dr. Clamon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-1932Fax+1 319-353-8377- Is this information wrong?
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1976 - 1977
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1974 - 1976- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1971 - 1972
- Washington University in St. Louis School of MedicineClass of 1971
Certifications & Licensure
IA State Medical License 1976 - 2024
MO State Medical License 1974 - 2016
WI State Medical License 1978 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 Start of enrollment: 2000 Feb 01
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Start of enrollment: 2000 Dec 18
Publications & Presentations
PubMed
- 7 citationsInflammation as a Therapeutic Target in Cancer Cachexia.Gerald Clamon, Margaret M Byrne, Erin E Talbert> ;Cancers. 2022 Oct 26
- A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.Paula M Fracasso, Sherry A Goodner, Jonathan D Wildi, Michael J Naughton, Gerald P Linette, Ramaswamy Govindan, Benjamin R Tan, Kristie A Blum, Gary J Jones, Tillman E...> ;American Journal of Clinical Oncology. 2022 Jul 1
- 3 citationsTransformational Changes Between Non-Small Cell and Small Cell Lung Cancer-Biological and Clinical Relevance-A Review.Gerald H. Clamon, William Zeitler, Josiah An, Taher Abu Hejleh> ;American Journal of Clinical Oncology. 2020 Sep 1
- Join now to see all
Grant Support
- Calgb 60301: Sorafenib For Solid Tumors And Hematologic MalignanciesNational Center For Research Resources2006
- University Of Iowa Calgb Institutional GrantNational Cancer Institute2004–2006
- Data &Safety MonitoringNational Cancer Institute2005
- Calgb 60101 Phase I Study Of OSI-774 For Solid TumorsNational Center For Research Resources2004–2005
- Calgb Institutional GrantNational Cancer Institute2003
- Univ Of Iowa Calgb Institutional GrantNational Cancer Institute1998–2002
- Cancer And Leukemia Group BNational Cancer Institute1993–1997
- University Of Iowa Institutional Calgb GrantNational Cancer Institute1988–1992
- Southeastern Cancer Study GroupNational Cancer Institute1986
Professional Memberships
- Member
Hospital Affiliations
University of Iowa Hospitals and ClinicsIowa City, Iowa
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
